Advocates fear New York state could be taking a step back when it comes to biomarker testing access for those with Medicaid.
Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.
A group of cancer survivors from around the state is set to gather outside Gov. Kathy Hochul’s Manhattan office on Tuesday.
A group of cancer survivors from the Bronx and statewide gathered outside Gov. Kathy Hochul’s NYC office on Third Avenue on ...
Not all memory lapses signal Alzheimer’s disease. Experts warn against rushing into tests, as stress, poor sleep, and anxiety ...
The demonstration was organized by the American Cancer Society Cancer Action Network and allied groups, which argue the ...
A bill requiring state-run insurance plans to pay for biomarker testing passed committee in an 8-1 vote today at the ...
Three years ago, New York state took a huge step forward expanding access to biomarker testing, which is said to be a game ...
Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove ...
Gov. Kathy Hochul’s Executive Budget would weaken the evidence-based standards in New York’s biomarker testing law, putting ...
A newly FDA-approved therapy is offering a different approach for patients with platinum-resistant ovarian cancer—an area ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results